Catégorie : News

SIGNIA THERAPEUTICS obtains EUROPEAN FUNDING in recognition of its major achievements and to ACCELERATE THE DEVELOPMENT OF ITS SIGNATURA® PLATFORM

mai 27, 2020

LYON, FRANCE (May 27, 2020) - Signia Therapeutics announced today that it has received a grant of € 2.38 millionfrom the E ...

Read more

Signia Therapeutics will be present at JP Morgan Healthcare Conference (Jan 13-15th 2020)

janvier 09, 2020

SIGNIA THERAPEUTICS will be in San Francisco fo ...

Read more

Signia Therapeutics, Cynbiose and the VirPath academic laboratory are partnering on an ambitious collaborative R&D project

décembre 09, 2019

Signia Therapeutics, Cynbiose and the VirPath academic laboratory are partnering on an ambitious collaborative R&D project to adv ...

Read more

Appointment of a Chief Business officer for Signia Therapeutics

novembre 18, 2019

Appointment of a Chief Business officer for Signia Therapeutics It is with a great pleasure that Signia Therapeutics announces the ar ...

Read more

Signia Therapeutics to be present at the Options for the Control of Influenza X Conference

août 20, 2019

Very pleased to announce that Dr. Andrés Pizzorno - Signia Therapeutics’ cofounder and Project Manager - has been invited by the Sc ...

Read more

Signia Therapeutics awarded with the label “French Tech Seed”

mars 15, 2019

Signia Therapeutics is very proud to announce it has been awarded with the label “French Tech Seed” by a wide and independent eval ...

Read more

1 2 3

Contact us

Do not hesitate to contact us!

Location

L’Atrium – 43 boulevard du 11 novembre 1918 69100 Villeurbanne, France

Phone

(+33) 478771037

Email

[email protected]

Leave a comment

Signia therapeutics.com - Copyright 2018. All right reserved.